Reference(s)
Click here to return to the Reference Table

Category: Hematopoietic Malignancies
Cancer type: Lymphomas
Descriptor: HGF/SF expression


Reference Number: 88
Eagles, G. et al. Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. Br J Cancer 73, 377-81 (1996).
PubMed link      E-mail link

Reference Number: 172
Capello, D. et al. The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma. Leukemia 14, 285-91. (2000).
PubMed link      E-mail link

Reference Number: 173
Gaidano, G. et al. Molecular characterization of HHV-8 positive primary effusion lymphoma reveals pathogenetic and histogenetic features of the disease. J Clin Virol 16, 215-24. (2000).
PubMed link      E-mail link

Reference Number: 174
Hsiao, L. T. et al. High serum hepatocyte growth factor level in patients with non- Hodgkin's lymphoma. Eur J Haematol 70, 282-9. (2003).
PubMed link      E-mail link

Reference Number: 175
Weimar, I. S. et al. Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Blood 89, 990-1000. (1997).
PubMed link      E-mail link

Reference Number: 268
Hsiao LT, Lin JT, Yu IT, Chiou TJ, Liu JH, Yen CC, Wang WS, Chen PM. High serum hepatocyte growth factor level in patients with non-Hodgkin's lymphoma. Eur J Maematol 70:282-9 (2003).
PubMed link      E-mail link

Reference Number: 429
Tjin EP, Groen RW, Vogelzang I, Derksen PW, Klok MD, Meijer HP, van Eeden S, Pals ST, Spaargaren M. Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma. Blood107, 760-8 (2006)
PubMed link      E-mail link

Reference Number: 431
Toyama T, Ido A, Sasak H, Maeda K, Yamashita K, Kubuki Y, Suzuki M, Matsuoka H, Tsubouchi H. Possible involvement of neutrophils in a serum level increase of hepatocyte growth factor in non-Hodgkin's lymphoma. Oncol Rep. 13, 439-44 (2005)
PubMed link      E-mail link

Reference Number: 432
Andersen NF, Standal T, Nielsen JL, Heickendorff L, Borset M, Sorensen FB, Abildgaard N. Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival. Br J Haematol. 128, 210-7 (2005)
PubMed link      E-mail link

Reference Number: 434
Tjin EP, Bende RJ, Derksen PW, van Huijstee AP, Kataoka H, Spaargaren M, Pals ST. Follicular dendritic cells catalyze hepatocyte growth factor (HGF) activation in the germinal center microenvironment by secreting the serine protease HGF activator. Immunol. 175, 2807-13 (2005)
PubMed link      E-mail link

Reference Number: 530
Passam FH, Alexandrakis MG, Moschandrea J, Sfiridaki A, Roussou PA, Siafakas NM. Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis. Int J Immunopathol Pharmacol. 19, 161-70 (2006)
PubMed link      E-mail link

Reference Number: 630
Etto L, Lacerda E, Baiocchi O, Silva V, Dalboni M, Alves A, Silva M, Vettore A, Colleoni G. Clinical correlations and prognostic relevance of HGF, VEGF AND FGF expression in Brazilian patients with non-Hodgkin lymphoma. Leuk Lymphoma. 49, 257-64 (2008)
PubMed link      E-mail link

Reference Number: 713
Ria R, Cirulli T, Giannini T, Bambace S, Serio G, Portaluri M, Ribatti D, Vacca A, Dammacco F. Serum levels of angiogenic cytokines decrease after radiotherapy in non-Hodgkin lymphomas. Clin Exp Med. 8,141-5 (2008) Epub 2008 Sep 13
PubMed link      E-mail link

Reference Number: 1149
Secchiero P, Corallini F, Zavan B, Tripodo C, Vindigni V, Zauli G. Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts. Invest New Drugs. 30, 803-7 (2012)
PubMed link      E-mail link